Replies to post #217751 on Biotech Values

[semi_infinite]

TRXC - Q1 release. 2 system sold in Q1 and 3 sold in current Q with several weeks left to go. Latest US sale to "major south central academic hospital". Of interest is the 1.3M recurring revenue booked in Q1 and higher ASP then analysts expectations wrt gross margins. 1.1M of the recurring revenue was from instrument sales. System rev was 3.5M.

http://ir.transenterix.com/news-releases/news-release-details/transenterix-inc-reports-operating-and-financial-results-first

CC has Q and comments regarding Verb and Medtronic.